Monoclonal antibodies specific to VEGF receptors and uses thereof
US5955311A · kind A · utility
23Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 1998 |
| Grant date | Sep 21, 1999 |
| Priority date | — |
| Expiry date | Mar 25, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Monoclonal antibodies that specifically bind to an extracellular domain of a VEGF receptor and neutralize activation of the receptor are provided. In vitro and in vivo methods of using these antibodies are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.